Children with osteogenesis imperfecta treated with bisphosphonates have site-specific bone responses to therapy.

被引：0
|
作者：
Fuchs, RK
Peacock, M
McClintock, C
DiMerlio, LA
机构：
[1] Indiana Univ, Sch Med, Dept Anat & Cell Biol, Indianapolis, IN USA
[2] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN USA
[3] Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN 46202 USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2005年 / 20卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S302 / S302
页数：1
相关论文
共 50 条
  • [31] Evidence that Abnormal High Bone Mineralization in Growing Children with Osteogenesis Imperfecta is not Associated with Specific Collagen Mutations
    Paul Roschger
    Nadja Fratzl-Zelman
    Barbara M. Misof
    Francis H. Glorieux
    Klaus Klaushofer
    Frank Rauch
    Calcified Tissue International, 2008, 82 : 263 - 270
  • [32] Rapid site-specific bone growth by a combination of bone marrow ablation and anabolic therapy
    Zhang, Q.
    Cuartas, E.
    Kotas, M.
    Ma, M.
    Rajan, S.
    Saltzman, M. W.
    Ke, D.
    Chalouni, C.
    Carlson, J.
    Gilligan, J.
    Mehta, N.
    Vignery, A.
    BONE, 2007, 40 (06) : S176 - S177
  • [33] Quality of life in children with osteogenesis imperfecta treated with oral bisphosphonates (Olpadronate): a 2-year randomized placebo-controlled trial
    Kok, Dieke H. J.
    Sakkers, Ralph J. B.
    Janse, Arieke J.
    Pruijs, Hans E. H.
    Verbout, Ab J.
    Castelein, Rene M.
    Engelbert, Raoul H. H.
    EUROPEAN JOURNAL OF PEDIATRICS, 2007, 166 (11) : 1155 - 1161
  • [34] Quality of life in children with osteogenesis imperfecta treated with oral bisphosphonates (Olpadronate): a 2-year randomized placebo-controlled trial
    Dieke H. J. Kok
    Ralph J. B. Sakkers
    Arieke J. Janse
    Hans E. H. Pruijs
    Ab J. Verbout
    Rene M. Castelein
    Raoul H. H. Engelbert
    European Journal of Pediatrics, 2007, 166 : 1155 - 1161
  • [35] Theoretical and experimental design of site-specific applicators and heating protocols for interstitial ultrasound thermal therapy.
    Tyréus, PD
    Nau, W
    Wu, A
    Diederich, C
    THERMAL TREATMENT OF TISSUE: ENERGY DELIVERY AND ASSESSMENT II, 2003, 4954 : 159 - 171
  • [36] Progression patterns and site-specific responses in advanced gastric cancer patients treated with nivolumab
    Kadono, Toru
    Iwasa, Satoru
    Nagashima, Kengo
    Oshima, Kotoe
    Yamamoto, Shun
    Hirano, Hidekazu
    Okita, Natsuko
    Shoji, Hirokazu
    Honma, Yoshitaka
    Takashima, Atsuo
    Kato, Ken
    Ushijima, Toshikazu
    Boku, Narikazu
    CANCER MEDICINE, 2023, 12 (08): : 9322 - 9331
  • [37] Rapid site-specific bone growth by a combination of bone marrow ablation, PTH and biphosphonate therapy
    Zhan, Q.
    Carlson, J.
    Cuartas, E.
    Kim, M.
    Mehta, N.
    Gilligan, J.
    Kotas, M.
    Ma, M.
    Raian, S.
    Saltzman, M. W.
    Chalouni, C.
    Vignery, A.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S397 - S397
  • [38] Two mosaics for COL1A1 mutations causing type III and IV osteogenesis imperfecta have a high percent of mutant bone cells: Implications for cell/gene therapy.
    Cabral, W
    Marini, JC
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 201 - 201
  • [39] Site-specific differences in bone mass between SA children of different ethnic groups
    Micklesfield, L. K.
    Norris, S.
    Nelson, D.
    Lambert, E. V.
    van der Merwe, L.
    Pettifor, J.
    BONE, 2007, 40 (06) : S244 - S245
  • [40] SITE-SPECIFIC RESPONSES AND EXTRANODAL INVOLVEMENT IMPLICATIONS IN LARGE B-CELL LYMPHOMAS TREATED WITH CD19-CART THERAPY
    de Abia, Alejandro Luna
    Devlin, Sean M.
    Flynn, Jessica
    de Lapuerta, Magdalena Corona
    Luttwak, Efrat
    Landego, Ivan
    Dahi, Parastoo B.
    Lin, Richard J.
    Parascondola, Allison
    Palomba, M. Lia
    Shah, Gunjan L.
    Scordo, Michael
    Imber, Brandon S.
    Tomas, Ana Alarcon
    Salles, Gilles
    Park, Jae H.
    Perales, Miguel-Angel
    Shouval, Roni
    BONE MARROW TRANSPLANTATION, 2024, 59 : 43 - 44
12345